24 studies found for:    Guillain-Barré Syndrome
Show Display Options
RSS Create an RSS feed from your search for:
Guillain-Barré Syndrome
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting International Guillain-Barré Syndrome Outcome Study
Conditions: Guillain-Barré Syndrome;   Miller Fisher Syndrome
Intervention:
2 Unknown  Safety Study of GBS Following Menactra Meningococcal Vaccination
Condition: Guillain-Barre Syndrome
Intervention:
3 Completed Intravenous Immunoglobulin (IVIG) Versus Plasma Exchange (PE) for Ventilated Children With Guillain Barre Syndrome (GBS)
Condition: Guillain Barre Syndrome
Interventions: Drug: IVIG;   Procedure: Plasma Exchange
4 Suspended Randomized Study of Plasmapheresis or Human Immunoglobulin Infusion in Childhood Guillain-Barre Syndrome
Condition: Guillain-Barre Syndrome
Intervention: Drug: Immune globulin
5 Completed Assessment of Chronic Guillain-Barre Syndrome Improvement With Use of 4-Aminopyridine
Condition: Guillain-Barre Syndrome
Intervention: Drug: 4-aminopyridine (4-AP)
6 Completed Early Mechanical Ventilation for Guillain Barré Syndrome
Conditions: Guillain Barré Syndrome;   Acute Respiratory Failure
Interventions: Procedure: mechanical ventilation;   Procedure: physiotherapy and oxygen if needed
7 Unknown  The Changes of Cytokines in Guillain Barré Syndrome: the Correlation With Clinical Manifestations and Skin Innervation
Condition: Guillain Barré Syndrome
Intervention:
8 Unknown  Prospective Study on Swallowing/Breathing Interactions in Severe Guillain Barre Syndrome.
Conditions: Tetraplegia;   Respiratory Failure
Intervention:
9 Not yet recruiting Inhibition of Complement Activation (Eculizumab) in Guillain-Barre Syndrome Study
Condition: Gullian Barre Syndrome
Intervention: Drug: Eculizumab
10 Completed Brain Computer Interface for Communication in ICU: a Feasibility Study
Conditions: Tetraplegia;   Guillain-Barre Syndrome
Intervention:
11 Active, not recruiting Cervarix Long-term Safety Surveillance
Conditions: Myositis;   Guillain-Barre Syndrome;   Autoimmune Thyroiditis;   Multiple Sclerosis;   Cutaneous Lupus;   Lupus Erythematosus;   Inflammatory Arthritis;   Type 1 Diabetes;   Central Demyelination;   Dermatomyositis;   Idiopathic Thrombocytopenic Purpura;   Graves Disease
Interventions: Biological: Cervarix;   Other: Data collection
12 Not yet recruiting Change of Nerve Conduction Properties in IVIg Dependent Neuropathies
Conditions: Guillain-Barre Syndrome;   CIDP;   Multifocal Motor Neuropathy
Intervention:
13 Recruiting Regional Citrate Anticoagulation in Plasma Exchange Treatment
Conditions: Focal Segmental Glomerulosclerosis;   Guillain-Barre Syndrome
Intervention: Procedure: plasma exchange treatment
14 Not yet recruiting Perception and Multisensory Integration in Neurological Patients Using fMRI
Conditions: Acute Inflammatory Demyelinating Polyradiculoneuropathy;   Myasthenia Gravis;   Stroke;   Anosognosia;   Asomatognosia
Intervention: Device: Siemens magnetom avanto1.5 Tesla, Siemens magnetom trio A Tim system 3 Tesla
15 Recruiting Postmarketing Safety Study of Q/LAIV in Subjects 2 Through 49 Years of Age
Condition: Observation Safety
Intervention:
16 Completed Additional 6-Month Safety Follow-up After Completion of Precursor Study 880801
Condition: Prophylaxis of Ross River Virus Infection
Intervention: Biological: Ross River Virus (RRV) Vaccine
17 Recruiting Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine Administered 6 Years Post-MenC Primary Vaccination in Healthy Subjects Who Were 12-18 Months at Primary Vaccination
Condition: Infections, Meningococcal
Intervention: Biological: Meningococcal conjugate vaccine GSK134612
18 Unknown  Detection of Peripheral Blood Biomarkers in Intermediate Phase Spinal Cord Injury: Correlation With Neurological and Functional Outcomes, and Comparison to Other Central and Peripheral Neurological Conditions.
Condition: Spinal Cord Injury
Intervention:
19 Not yet recruiting Study to Evaluate the Long-term Antibody Persistence of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine (GSK134612) Versus Mencevax ACWY in Healthy Adolescents and Adults and Booster Response to MenACWY-TT Vaccine Administered at 10 Years Post-primary Vaccination
Condition: Infections, Meningococcal
Intervention: Biological: Meningococcal vaccine GSK134612
20 Completed
Has Results
Surveillance for Adverse Events Following Pandemic H1N1 Immunization
Condition: Novel Influenza A/H1N1
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results
Indicates status has not been verified in more than two years